These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8381184)

  • 1. Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes.
    Jacobs RT; Brown FJ; Cronk LA; Aharony D; Buckner CK; Kusner EJ; Kirkland KM; Neilson KL
    J Med Chem; 1993 Feb; 36(3):394-409. PubMed ID: 8381184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3,6-trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent.
    Brown FJ; Cronk LA; Aharony D; Snyder DW
    J Med Chem; 1992 Jun; 35(13):2419-39. PubMed ID: 1320123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationships, and pharmacological evaluation of a series of fluorinated 3-benzyl-5-indolecarboxamides: identification of 4-[[5-[((2R)-2-methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methyl indol- 3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a potent, orally active antagonist of leukotrienes D4 and E4.
    Jacobs RT; Bernstein PR; Cronk LA; Vacek EP; Newcomb LF; Aharony D; Buckner CK; Kusner EJ
    J Med Chem; 1994 Apr; 37(9):1282-97. PubMed ID: 8176706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.
    Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.
    Matassa VG; Maduskuie TP; Shapiro HS; Hesp B; Snyder DW; Aharony D; Krell RD; Keith RA
    J Med Chem; 1990 Jun; 33(6):1781-90. PubMed ID: 2342072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Grimes D; Carlson RP; Hand JM; Chang J
    J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency.
    Galemmo RA; Johnson WH; Learn KS; Lee TD; Huang FC; Campbell HF; Youssefyeh R; O'Rourke SV; Schuessler G; Sweeney DM
    J Med Chem; 1990 Oct; 33(10):2828-41. PubMed ID: 2170649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure-activity relationships of 1,6-disubstituted indoles and indazoles.
    Brown FJ; Yee YK; Cronk LA; Hebbel KC; Krell RD; Snyder DW
    J Med Chem; 1990 Jun; 33(6):1771-81. PubMed ID: 2342071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of antiallergic N-[4-[4-(1H-indol-3-yl)piperidinoalkyl]-2-thiazolyl]alkanamides possessing both antihistaminic and anti slow-reacting substance (SRS) activities.
    Shigenaga S; Manabe T; Matsuda H; Fujii T; Matsuo M
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1822-7. PubMed ID: 7954933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents.
    Tilley JW; Levitan P; Lind J; Welton AF; Crowley HJ; Tobias LD; O'Donnell M
    J Med Chem; 1987 Jan; 30(1):185-93. PubMed ID: 2879917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New N-pyridinyl(methyl)-indole-2- and 3-(alkyl)carboxamides and derivatives acting as systemic and topical inflammation inhibitors.
    Breteche A; Duflos M; Dassonville A; Nourrisson MR; Brelet J; Le Baut G; Grimaud N; Petit JY
    J Enzyme Inhib Med Chem; 2002 Dec; 17(6):415-24. PubMed ID: 12683678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
    Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH
    Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
    Lattmann E; Singh H; Boonprakob Y; Lattmann P; Sattayasai J
    J Pharm Pharmacol; 2006 Mar; 58(3):393-401. PubMed ID: 16536908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
    Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y
    Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
    O'Sullivan BP; Mong S
    Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
    Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
    J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New indole amide derivatives as potent CRTH2 receptor antagonists.
    Zaghdane H; Boyd M; Colucci J; Simard D; Berthelette C; Leblanc Y; Wang Z; Houle R; Lévesque JF; Molinaro C; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Gallant M
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3471-4. PubMed ID: 21515053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents.
    Yeung KS; Qiu Z; Xue Q; Fang H; Yang Z; Zadjura L; D'Arienzo CJ; Eggers BJ; Riccardi K; Shi PY; Gong YF; Browning MR; Gao Q; Hansel S; Santone K; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):198-202. PubMed ID: 23200252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
    Cowley PM; Baker J; Barn DR; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Goodwin RR; Jaap D; Kiyoi Y; Mort C; Palin R; Prosser A; Walker G; Ward N; Wishart G; Young T
    Bioorg Med Chem Lett; 2011 Jan; 21(1):497-501. PubMed ID: 21075628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.